+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wearable Injectors Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • ID: 4662978
  • Report
  • September 2018
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • Becton
  • CeQur SA.
  • Debiotech S.A.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Sensile Medical AG
  • MORE
The report on global wearable injectors market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global wearable injectors market to grow with a CAGR of 13.4% over the forecast period of 2018-2024. The study on wearable injectors market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The report on wearable injectors market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global wearable injectors market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global wearable injectors market over the period of 2016 to 2024. Further, the growth matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.

The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Report Findings

1. Drivers
  • High Prevalence of Chronic Diseases, Cardiovascular Disease, Blood Disorders, And Infectious Disease
  • Growing Popularity among Patients Related to Wearable Devices
  • Rising Incidences of Needlestick Injuries
  • Adoption of Technologically Advanced Products
2. Restraints
  • ?Preference towards Alternative Drug Delivery Modes
3. Opportunities
  • Recent Advancement in the Wearable Technology
Segment Covered

The global wearable injectors market is segmented on the basis of type, application and end use industry.

Global Wearable Injectors Market by Type
  • Body Worn Pathch Injectors
  • Off Body Worn Pathch Injectors
Global Wearable Injectors Market by Application
  • Oncology
  • Infectious Disease
  • Cardiovascular Disease
  • Autoimmune Disease
  • Diabetes
Global Wearable Injectors Market by End Use Industry
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Clinics
  • Hospitals
  • Clinics
  • Home Care Settings
  • Others
Company Profiles
  • Becton
  • SteadyMed Therapeutics, Inc
  • Sensile Medical AG
  • Debiotech S.A.
  • CeQur SA.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • F. Hoffmann-La Roche Ltd.
What does this report deliver?

1. Comprehensive analysis of global as well as regional markets of wearable injectors market.

2. Complete coverage of all the segments in wearable injectors market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in the global wearable injectors market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Becton
  • CeQur SA.
  • Debiotech S.A.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Sensile Medical AG
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Wearable Injectors Market Highlights
2.2. Wearable Injectors Market Projection
2.3. Wearable Injectors Market Regional Highlights

3. Global Wearable Injectors Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by End Use Industry
3.4.4. Growth Matrix Analysis by Region
3.5. Value chain wearable injectors market
3.6. Import-Export data matrix

4. Wearable Injectors Market Macro Indicator Analysis

5. Global Wearable Injectors Market by Type
5.1. Body Worn Pathch Injectors
5.2. Off Body Worn Pathch Injectors

6. Global Wearable Injectors Market by Application
6.1. Oncology
6.2. Infectious Disease
6.3. Cardiovascular Disease
6.4. Autoimmune Disease
6.5. Diabetes

7. Global Wearable Injectors Market by End Use Industry
7.1. Retail Pharmacies
7.2. Online Pharmacies
7.3. Speciality Clinics
7.4. Hospitals
7.5. Clinics
7.6. Home Care Settings
7.7. Others

8. Global Wearable Injectors Market by Region 2018-2024
8.1. North America
8.1.1. North America Wearable Injectors Market by Type
8.1.2. North America Wearable Injectors Market by Application
8.1.3. North America Wearable Injectors Market by End Use Industry
8.1.4. North America Wearable Injectors Market by Country
8.2. Europe
8.2.1. Europe Wearable Injectors Market by Type
8.2.2. Europe Wearable Injectors Market by Application
8.2.3. Europe Wearable Injectors Market by End Use Industry
8.2.4. Europe Wearable Injectors Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Wearable Injectors Market by Type
8.3.2. Asia-Pacific Wearable Injectors Market by Application
8.3.3. Asia-Pacific Wearable Injectors Market by End Use Industry
8.3.4. Asia-Pacific Wearable Injectors Market by Country
8.4. RoW
8.4.1. RoW Wearable Injectors Market by Type
8.4.2. RoW Wearable Injectors Market by Application
8.4.3. RoW Wearable Injectors Market by End Use Industry
8.4.4. RoW Wearable Injectors Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Wearable Injectors Market
9.2. Companies Profiles
9.2.1. Becton
9.2.1.1. Overview
9.2.1.2. Company Snapshot
9.2.1.3. Financial Snapshot
9.2.1.4. Product portfolio
9.2.1.5. Recent developments
9.2.2. Steadymed Therapeutics, Inc
9.2.2.1. Overview
9.2.2.2. Company Snapshot
9.2.2.3. Financial Snapshot
9.2.2.4. Product portfolio
9.2.2.5. Recent developments
9.2.3. Sensile Medical Ag
9.2.3.1. Overview
9.2.3.2. Company Snapshot
9.2.3.3. Financial Snapshot
9.2.3.4. Product portfolio
9.2.3.5. Recent developments
9.2.4. Debiotech S.a.
9.2.4.1. Overview
9.2.4.2. Company Snapshot
9.2.4.3. Financial Snapshot
9.2.4.4. Product portfolio
9.2.4.5. Recent developments
9.2.5. Cequr Sa.
9.2.5.1. Overview
9.2.5.2. Company Snapshot
9.2.5.3. Financial Snapshot
9.2.5.4. Product portfolio
9.2.5.5. Recent developments
9.2.6. West Pharmaceutical Services, Inc.
9.2.6.1. Overview
9.2.6.2. Company Snapshot
9.2.6.3. Financial Snapshot
9.2.6.4. Product portfolio
9.2.6.5. Recent developments
9.2.7. Ypsomed Ag
9.2.7.1. Overview
9.2.7.2. Company Snapshot
9.2.7.3. Financial Snapshot
9.2.7.4. Product portfolio
9.2.7.5. Recent developments
9.2.8. Insulet Corporation
9.2.8.1. Overview
9.2.8.2. Company Snapshot
9.2.8.3. Financial Snapshot
9.2.8.4. Product portfolio
9.2.8.5. Recent developments
9.2.9. Tandem Diabetes Care, Inc.
9.2.9.1. Overview
9.2.9.2. Company Snapshot
9.2.9.3. Financial Snapshot
9.2.9.4. Product portfolio
9.2.9.5. Recent developments
9.2.10. F. Hoffmann-la Roche Ltd.
9.2.10.1. Overview
9.2.10.2. Company Snapshot
9.2.10.3. Financial Snapshot
9.2.10.4. Product portfolio
9.2.10.5. Recent developments

10. Appendix
10.1. Primary research findings and questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Becton
  • SteadyMed Therapeutics, Inc
  • Sensile Medical AG
  • Debiotech S.A.
  • CeQur SA.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • F. Hoffmann-La Roche Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll